2019新型冠状病毒核酸检测试剂优化、验证及分析

doi:10.6040/j.issn.1671-7554.0.2020.0923

摘要/Abstract

摘要： 目的优化敏感性及特异性更高的新型冠状病毒(2019-nCoV)核酸检测试剂盒,提高阳性检出率。并与市售试剂盒进行对比,对临床使用提出指导。方法收集2020年1月至3月在山东大学附属济南市中心医院等6家2019-nCoV核酸检测单位的确诊患者88例及阴性患者572例,共计660例。通过对2019-nCoV的全基因组进行序列分析,设计更加灵敏的引物、探针,优化buffer配比及扩增过程。采用交叉实验及内源性物质干扰实验评价其特异性。另外选择3家市售核酸检测试剂盒,对梯度稀释的阳性核酸样本进行对比验证实验。结果优化后的开放读码框1a/b(ORF1ab)、核衣壳蛋白(N)对于2019-nCoV的RNA靶点,比市售试剂盒具有更高的灵敏度。当核酸样本中1个病毒浓度为1个拷贝时即可检出,同时扩增曲线更加优越。相比较与世界卫生组织(WHO)或自行设计引物的试剂盒,ORF1ab的灵敏度提高了2倍(1∶10 vs 1∶5);而N基因的灵敏度比中国疾病预防控制中心(CDC)和自行设计引物的试剂盒提高了8倍(1∶80 vs 1∶10),比WHO试剂盒提高了2倍(1∶80 vs 1∶40)。临床验证实验显示,鼻咽拭子检测准确度均为100%,与其他感染部位相同或感染症状相似的其他病原体无交叉反应,试剂盒的分析特异性为100%,阳性符合率和阴性符合率均为100%。结论优化后的2019-nCoV核酸检测试剂盒具有更高的检测灵敏度和特异性,有助于解决核酸检测假阴性,提高阳性率,将对低病毒载量患者及出院患者的判定具有重要的意义。

关键词: 新型冠状病毒, 低病毒载量, 假阴性, 灵敏度, 特异性

Abstract: Objective To optimize the sensitivity and specificity of a 2019-nCoV nucleic acid detection kit, so as to improve the positive detection rate and provide guidance for clinical use by comparison with different kits. Methods From January to March 2020, 88 confirmed and 572 negative specimens of 2019-nCoV were recruited from 6 2019-nCOV nucleic acid testing centers including Jinan Central Hospital Affiliated to Shandong University. By sequence analysis of the whole genome of 2019-nCoV, a more sensitive primer and probe were designed to optimize the buffer ratio and amplification process. The sensitivity was evaluated with cross-reactive experiment and endogenous substances interference test. The optimized kit and 3 other commercial kits were compared with gradient dilution tests. Results The optimized ORF1ab and N gene had higher sensitivity to the RNA targets of 2019-nCoV. When the concentration of virus was 1, the virus could be detected, and the amplification curve was better than the commercial kits. The sensitivity of ORF1ab was increased by 2 times(1∶10 vs 1∶5)compared with WHO or other self-designed kits, and the sensitivity of N gene was increased by 8 times(1∶80 vs 1∶10)and 2 times(1∶80 vs 1∶40)compared with CDC and WHO kits respectively. The results of cross-reactive test and endogenous substances interference test showed that the accuracy of nasopharyngeal swabs was 100%, there was no cross-reaction with other pathogens with similar infection symptoms, and the accuracy and specificity of the kit were 100%. Conclusion The optimized 2019-nCoV nucleic acid detection kit has higher sensitivity and specificity, which is helpful to solve the false negative nucleic acid detection and increase the positive rate, and is significant to formulate discharge criteria of low viral load patients.

Key words: Novel coronavirus, Low viral load, False negative, Sensitivity, Specificity

中图分类号:

R574

周云英,张通,钊倩倩,王海岩,汪运山. 2019新型冠状病毒核酸检测试剂优化、验证及分析[J]. 山东大学学报 (医学版), 2020, 58(10): 127-133.

ZHOU Yunying, ZHANG Tong, ZHAO Qianqian, WANG Haiyan, WANG Yunshan. Optimization, validation and analysis of a 2019-nCoV nucleic acid detection kit[J]. Journal of Shandong University (Health Sciences), 2020, 58(10): 127-133.

参考文献

[1] Wang C, Horby PW, Hayden FG, et al. A novel coronavirus outbreak of global health concern[J]. Lancet, 2020, 395(10223):470-473.
[2] Munster VJ, Koopmans M, van Doremalen N, et al. A novel coronavirus emerging in China-Key questions for impact assessment[J]. N Engl J Med, 2020, 382(8):692-694.
[3] Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019[J]. N Engl J Med, 2020, 382(8):727-733.
[4] Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China[J]. JAMA, 2020, 323(11):1061-1069.
[5] 李士雪, 单莹. 新型冠状病毒肺炎研究进展述评[J].山东大学学报(医学版), 2020, 58(3):19-25. LI Shixue, SHAN Ying. Latest research advances on novel coronavirus pneumonia[J]. Journal of Shandong University(Health Sciences), 2020, 58(3):19-25.
[6] Yan R, Zhang Y, Li Y, et al. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2[J]. Science, 2020, 367(6485):1444-1448.
[7] Zhang L, Lin D, Sun X, et al. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved alpha-ketoamide inhibitors[J]. Science, 2020, 368(6489):409-412.
[8] National Genomics Data Center Members and Partners. Database Resources of the National Genomics Data Center in 2020[J]. Nucleic Acids Res, 2020, 48(1): 24-33.
[9] Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China[J]. Nature, 2020, 579(7798):265-269.
[10] Angeletti S, Benvenuto D, Bianchi M, et al. COVID-2019: The role of the nsp2 and nsp3 in its pathogenesis[J]. J Med Virol, 2020, 92(6):584-588.
[11] 国家药品监督管理局.国家药监局应急审批新型冠状病毒检测产品[EB/OL].(2020-03-16)[2020-06-05].http://www.nmpa.gov.cn/WS04/CL2578/375802.html.
[12] 郭雅琼,张笠,鲁彦.新型冠状病毒引起的临床相关疾病及其分子生物学检测[J/OL].检验医学与临床,2020.http://kns.cnki.net/kcms/detail/50.1167.R.20200316.1810.002.html.
[13] 郭元元, 王昆, 张宇, 等. 6 种国产新型冠状病毒核酸检测试剂检测性能比较与分析[J]. 重庆医学, 2020, 49(15):2435-2439. GUO Yuanyuan, WANG Kun, ZHANG Yu, et al. Comparison and analysis of the detection performance of six SARS-CoV-2 nucleic acid detection reagents[J]. Chongqing Medicine, 2020, 49(15):2435-2439.
[14] Zou L, Ruan F, Huang M, et al. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients[J]. N Engl J Med, 2020, 382(12):1177-1179.
[15] Su YC, Anderson DE, Young BE, et al. Discovery of a 382-nt deletion during the early evolution of SARS-CoV-2[J]. bioRxiv, 2020. doi:10.1101/2020.03.11.987222.
[16] Corman VM, Landt O, Kaiser M, et al. Detection of 2019 novel coronavirus(2019-nCoV)by real-time RT-PCR[J]. Euro Surveill, 2020, 25(3): 2000045.
[17] 国家卫生健康委员会办公厅.新型冠状病毒肺炎实验室检测技术指南[EB/OL].(2020-03-09)[2020-06-05]. http://www.chinacdc.cn/jkzt/crb/zl/szkb11803/jszl11815/202003/t20200309214241.html.
[18] Barra GB, Santa Rita TH, Mesquita PG, et al. Analytical sensibility and specificity of two RT-qPCR protocols for SARS-CoV-2 detection performed in an automated workflow[J]. medRxiv, 2020. doi:10.1101/2020.03.07.20032326.
[19] Diao B, Wen K, Chen J, et al. Diagnosis of Acute Respiratory Syndrome Coronavirus 2 Infection by Detection of Nucleocapsid Protein[J]. medRxiv, 2020. doi: 10.1101/2020.03.07.20032524.
[20] Broughton JP, Deng X, Yu G, et al. Rapid Detection of 2019 Novel Coronavirus SARS-CoV-2 Using a CRISPR-based DETECTR Lateral Flow Assay[J]. medRxiv, 2020. doi:10.1101/2020.03.06.20032334.
[21] 钟慧钰, 赵珍珍, 宋兴勃, 等. 新型冠状病毒临床检测要点及经验[J].国际检验医学杂志,2020,41(5):523-526. ZHONG Huiyu, ZHAO Zhenzhen, SONG Xingbo, et al. Clinal points and experience in nucleic acid testing of SARS-Cov-2[J]. International Journal of Laboratory Medicine, 2020, 41(5):523-526.
[22] Lan L, Xu D, Ye G, et al. Positive RT-PCR test results in patients recovered from COVID-19[J]. JAMA, 2020, 323(15):1502-1503.
[23] Zhang W, Du RH, Li B, et al. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes[J]. Emerg Microbes Infect, 2020, 9(1):386-389.
[24] 赵怀龙, 吕燕, 赵红. 济南市47例新型冠状病毒肺炎患者取样部位对核酸检测结果的影响[J].山东大学学报(医学版), 2020, 58(4):28-31. ZHAO Huailong, LU Yan, ZHAO Hong. Effect of sampling in mucleic acid test on the test result: a report from 47 confirmed COVID-19 cases in Jinan City[J]. Journal of Shandong University(Health Sciences), 2020, 58(4):28-31.

相关文章 15

[1]	李晶,鞠苇杭,刘珂. 泛癌细胞类型特异性基因共表达模式[J]. 山东大学学报 (医学版), 2025, 63(9): 31-39.
[2]	张学宇,张学海,孙文青,刘晗,姜金波,刘寒,李远,陈晓梅. 重症新型冠状病毒肺炎伴侵袭性肺曲霉病及反复致命性消化道出血1例[J]. 山东大学学报 (医学版), 2024, 62(7): 56-61.
[3]	王玉淼,崔晓霈,张红雨. 高龄老年新型冠状病毒肺炎患者应用抗凝治疗的短期疗效和安全性[J]. 山东大学学报 (医学版), 2024, 62(12): 21-31.
[4]	王骏仁,李道卫,王星光,姜淑娟. 吸入布地奈德/福莫特罗治疗新型冠状病毒感染后咳嗽的疗效[J]. 山东大学学报 (医学版), 2023, 61(8): 50-53.
[5]	高丽鹤,任婧婧,李岩,李强,马万山,李焕杰,陈振,欧兰香,张绍明,朱之炜,丁兴龙,李红霞,王岩,张忠法,汪运山. 新型冠状病毒中和抗体酶联免疫检测试剂盒的制备及应用[J]. 山东大学学报 (医学版), 2023, 61(4): 77-85.
[6]	王园园,孙云. 合并新型冠状病毒肺炎的维持性血液透析患者死亡危险因素[J]. 山东大学学报 (医学版), 2023, 61(11): 68-73.
[7]	吴文静,孙媛,王光裕,吕晓晴,焉传祝,林鹏飞. 1例女性杜氏肌营养不良的分子遗传学机制[J]. 山东大学学报 (医学版), 2023, 61(10): 95-100.
[8]	陈兆波,方敏,薛浩然,刘春艳. 去泛素化酶USP35促进非小细胞肺癌细胞迁移和侵袭[J]. 山东大学学报 (医学版), 2022, 60(4): 30-37.
[9]	曹义海. 血管生成在疾病治疗中的应用与展望[J]. 山东大学学报 (医学版), 2021, 59(9): 9-14.
[10]	杨璇,李岩志,马伟,贾崇奇. 基于两样本孟德尔随机化的肺功能与新型冠状病毒肺炎病死风险的因果关系[J]. 山东大学学报 (医学版), 2021, 59(7): 104-111.
[11]	周溪,黄霂晗,任玉洁,邱洋. 新型冠状病毒感染与天然免疫及炎症反应[J]. 山东大学学报 (医学版), 2021, 59(5): 15-21.
[12]	董宏杰,张俊梅,王帅,王宏伟,张坤迪,胡玮,谢晓鸿,谢时灵,谷立川. 新型冠状病毒混合样品检测研究[J]. 山东大学学报 (医学版), 2021, 59(4): 1-5.
[13]	于莹,张功,刘晶,颜世童,韩涛,黄海量. 基于网络药理学和分子对接方法探析黄芪预防新型冠状病毒肺炎的潜在作用机制[J]. 山东大学学报 (医学版), 2021, 59(4): 6-16.
[14]	任敏敏,王广梅,张丽,杨瑶瑶,封丹珺. 335名抗疫一线护理人员心理弹性对共情疲劳的影响[J]. 山东大学学报 (医学版), 2021, 59(2): 88-94.
[15]	董宏杰,张俊梅,王宏伟,王茂凤,张坤迪,张冯瑜,王帅,胡玮,谢时灵,谷立川. 新型冠状病毒核酸检测过程中灵敏度损失的定量分析[J]. 山东大学学报 (医学版), 2021, 59(1): 1-7.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed